Primary prevention of venous thromboembolism for cancer patients in randomized controlled trials: a bibliographical analysis of funding and trial characteristics

CONCLUSION: There were few significant differences between trial characteristics, suggesting that the evidence from commercially sponsored trials investigating VTE prophylaxis in patients with cancer is unlikely to be subject to bias attributable to commercial sponsorship.PMID:38404943 | PMC:PMC10884502 | DOI:10.1016/j.rpth.2024.102315

Source: Thrombosis and Haemostasis - February 26, 2024 Category: Hematology Authors: Lucy Zhao Jayhan Kherani Pei Ye Li Kevin Zhang Angelina Horta Christine Lin Allen Li Ali Eshaghpour Mark Andrew Crowther Source Type: research